CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance

Identification of effective prognostic biomarkers and targets are of crucial importance to the management of estrogen receptor positive (ER+) breast cancer. CCNA2 (also known as CyclinA2) belongs to the highly conserved cyclin family and is significantly overexpressed in various cancer types. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tian, Han, Yong, Yu, Ling, Ao, Sheng, Li, Ziyu, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951414/
https://www.ncbi.nlm.nih.gov/pubmed/24622579
http://dx.doi.org/10.1371/journal.pone.0091771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951414/
https://www.ncbi.nlm.nih.gov/pubmed/24622579
http://dx.doi.org/10.1371/journal.pone.0091771

Ejemplares similares